LORD, ABBETT & CO. LLC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$12,036,000
+63.8%
782,554
+81.5%
0.01%
-17.6%
Q1 2014$7,348,000
-32.6%
431,201
-48.8%
0.02%
-29.2%
Q4 2013$10,910,000
+20.9%
842,468
-5.7%
0.02%
+14.3%
Q3 2013$9,027,000
+88.5%
893,770
+39.4%
0.02%
+90.9%
Q2 2013$4,790,000641,2330.01%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$22,357,00015.70%
VHCP Management, LLC 1,000,273$17,045,0008.86%
HARVEY CAPITAL MANAGEMENT INC 915,800$15,605,0006.22%
Baupost Group 6,310,850$107,537,0002.60%
SECTORAL ASSET MANAGEMENT INC 3,537,590$60,281,0002.48%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 587,504$10,011,0002.31%
Knoll Capital Management, LLC 200,000$3,408,0001.76%
Camber Capital Management LP 1,250,000$21,300,0001.67%
NORTHPOINTE CAPITAL LLC 877,875$14,958,0001.52%
DAFNA Capital Management LLC 100,000$1,704,0001.46%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders